Foresite Capital Management III, LLC - AKARI THERAPEUTICS PLC ownership

AKARI THERAPEUTICS PLC's ticker is AKTX and the CUSIP is 00972G108. A total of 14 filers reported holding AKARI THERAPEUTICS PLC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Foresite Capital Management III, LLC ownership history of AKARI THERAPEUTICS PLC
ValueSharesWeighting
Q4 2016$1,387,000
-17.3%
197,0720.0%0.60%
-23.1%
Q3 2016$1,677,000
-36.9%
197,0720.0%0.78%
-57.0%
Q2 2016$2,659,000
-28.0%
197,072
-25.3%
1.82%
-36.2%
Q1 2016$3,695,000
-3.4%
263,9210.0%2.86%
-15.8%
Q4 2015$3,827,000263,9213.39%
Other shareholders
AKARI THERAPEUTICS PLC shareholders Q1 2017
NameSharesValueWeighting ↓
VHCP Management II, LLC 426,297$2,617,0000.72%
Vivo Capital, LLC 345,850$2,124,0000.43%
Hikari Power Ltd 151,334$929,0000.12%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 433,551$2,662,0000.12%
NEA Management Company, LLC 452,167$2,776,0000.10%
Baker Brothers Advisors 496,901$3,051,0000.02%
HUNTINGTON NATIONAL BANK 8,000$49,0000.00%
MILLENNIUM MANAGEMENT LLC 115,543$709,0000.00%
DEUTSCHE BANK AG\ 5,300$32,0000.00%
MORGAN STANLEY 8,807$54,0000.00%
View complete list of AKARI THERAPEUTICS PLC shareholders